Since the early 1980’s Tufts Medical Center has been one of the Gynecologic Oncology Group (GoG) member academic medical centers. GOG is an organization funded by the National Cancer Institute to develop and execute clinical trials aimed at the effective treatment of gynecologic cancers.
The research laboratory of Young Bae Kim, MD, Chief of the Gynecologic Oncology Division at Tufts Medical Center, has continued the Division's involvement with the GOG, which allows Tufts Medical Center patients to gain access to innovative treatments involving surgery, radiation therapy, chemotherapy, biologic agents and cancer prevention.
Current studies include investigating intraperitoneal chemotherapy and dose-dense paclitaxel in advanced ovarian cancer as well as combined radiation and chemotherapy in advanced endometrial cancer.
Dr. Kim is also working with Anika Agarwal, MD, MPhil, a researcher in the Tufts Molecular Oncology Research Institute (MORI) to identify potential biomarkers for the detection of ovarian cancer.